Navigation Links
New Long-Term Study Suggests Lower Mortality in Alzheimer's Patients Treated with Galantamine Versus Placebo
Date:12/5/2012

to month 24, was significantly worse in the placebo group than in the galantamine group (P=0.002). The DAD is a validated measure of activities of daily living.

About the Study

The randomized, double-blind, placebo-controlled clinical study was designed to evaluate the safety and efficacy of long-term (two-year) treatment with galantamine in patients with mild to moderately severe Alzheimer's disease.

The primary safety endpoint was the rate of mortality or death over two years. The secondary safety endpoint was the incidence of treatment emergent adverse events, including serious adverse events, over two years.

Approximately 49 percent of the placebo group and 54 percent of the galantamine group reported at least one Treatment Emergent Adverse Event (TEAE). Approximately 12 percent of patients reported serious adverse events in both groups. Patients who were treated with galantamine reported numerically more TEAEs, most notably gastrointestinal disorders (nausea, vomiting). The incidence and types of serious AEs were similar in both groups, except for mortality, which was significantly higher in the group of patients that received placebo.

The primary efficacy endpoint was the change from baseline in the MMSE score at month 24. Secondary efficacy endpoints included cognitive change from baseline to month 6 as measured by the MMSE, and change in function from baseline to month 24 as measured by the DAD.

The trial enrolled 2,051 people (1,023 to the placebo group, 1,028 to the galantamine group) and was conducted at 127 sites in 13 countries. Patients in the study were between the ages of 45 and 92; their mean age was approximately 73 years. The majority of patients was female (65 percent).

The galantamine group initially received 8 mg of drug daily, and the dose was increased to 16 to 24 mg daily during the first 12 weeks of the study. Thereafter, patients were maintained on 16 to 24 mg of galantamine daily.<
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
2. Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets
3. New Study Shows Long-Term Effects of Drug Prevention
4. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
5. Unilife Signs Long-Term Supply Contract for the Unifill Prefilled Syringe
6. Vocollect Healthcare Systems And Prime Care Technologies Bring AccuNurse Key Performance Metrics To Long-Term Care Providers Via primeVIEW Digital Dashboard
7. GlaxoSmithKline Employees Embark on Long-Term Volunteer Assignments throughout the World
8. Savient Pharmaceuticals Announces CEO Appointment and Reorganization Plan to Drive Long-Term Growth
9. Long-Term Use of Blood Pressure Medications that Promote Sun Sensitivity May Increase Risk of Lip Cancer in Non-Hispanic Whites
10. Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan
11. Greenphires ClinCard Technology Platform selected by top 5 pharmaceutical company for long-term global clinical trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014 Somewhere between ... hearing health was forgotten. But Audicus , a ... hear better this new year. Hearing loss ... the aging population, though it is often unaddressed. Forty-eight ... four has a hearing aid, mainly due to price. ...
(Date:12/19/2014)... CITY, Calif., Dec. 18, 2014 Capnia, ... the development of medical diagnostics based on its ... gas flow, today announced financial results for the ... 2014. "Following the completion of our ... positioned to maximize the recently initiated CoSense® commercial ...
(Date:12/19/2014)... , Dec. 18, 2014   Aratana Therapeutics, ... biopharmaceutical company focused on the licensing, development and ... announced positive results from its pivotal field study ... treating pain in dogs with osteoarthritis.  In the ... assessment scores that were statistically significant compared to ...
Breaking Medicine Technology:Audicus Will Help People Resolve to Hear Better in 2015 2Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5
... , , , ... majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE ), ... the U.S. FDA, has cleared the Zargis Cardioscan(TM) device ... analysis software connects wirelessly to a Bluetooth®-enabled electronic stethoscope ...
... NATICK, Mass., Jan. 8 Boston Scientific Corporation (NYSE: ... from the Japanese Ministry of Health, Labor and Welfare (MHLW) ... treatment of coronary artery disease. The Company plans to ... which is expected in the coming weeks. , The PROMUS ...
Cached Medicine Technology:Zargis Cardioscan Cleared for Sale in Canada 2Zargis Cardioscan Cleared for Sale in Canada 3Boston Scientific Announces Japanese Approval for PROMUS(R) Everolimus-Eluting Coronary Stent System 2Boston Scientific Announces Japanese Approval for PROMUS(R) Everolimus-Eluting Coronary Stent System 3Boston Scientific Announces Japanese Approval for PROMUS(R) Everolimus-Eluting Coronary Stent System 4
(Date:12/20/2014)... LunaDress has recently announced its 2015 collection of ... on all of its special occasion dresses & wedding apparel. ... wedding gown. If you have no idea of what to ... different wedding dress styles and our dress experts are here ... current special offer, up to 80% off," the CEO of ...
(Date:12/20/2014)... holidays can be anything but joyous for people with ... and other allergy triggers. "The dust from the ... away in dank basements or dusty attics is triggering ... Shah, an affiliate faculty member at Loyola University Chicago ... Shah, who is also an allergist at Gottlieb ...
(Date:12/20/2014)... Angeldress.co.uk, the distinguished wedding dress manufacturer and retailer, has ... company has recently updated its official blog with the ... Angeldress Blog has recommended some new designs ... itself in offering a huge selection of elegant products ... outfits are very carefully selected based on the design ...
(Date:12/20/2014)... 2014 The aftermath of the November 24th ... not only in Hollywood, but worldwide. As reported ... ripples of that attack are starting a finger-pointing game which ... But they are not the only ones affected, regular ... for some embarrassing times ahead, agents and lawyers could be ...
(Date:12/20/2014)... Xarelto bleeding lawsuits filed by men ... and other serious side effects will be consolidated in ... coordinated pretrial proceedings, Wright &amp;amp; Schulte LLC reports. The ... order Friday to transfer 21 Xarelto lawsuits and over ... to the Louisiana district court for coordination by Judge ...
Breaking Medicine News(10 mins):Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2Health News:Holiday Trimmings Can Trigger Allergies 2Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 2Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 3Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 4
... 2009 - In a study by Miall, Gowen and Tchalenko ... ( http://www.elsevier.com/locate/cortex ), a brain scanner was used to ... of drawing faces. The researchers found that the captured visual ... plans to reach those locations. It is as if the ...
... April 1-5, 2009 at Marriott Wardman Park ... Osteoporosis Foundation (NOF) will bring together a ... relevant evidence-based information on bone health and ... of healthcare professionals at its comprehensive annual ...
... the Nebraska Medical AssociationOMAHA, Neb., March 19 With ... three months, it,s time for those who smoke to ... so on Wednesday, March 25, when school children throughout ... sponsored by the Campaign for Tobacco Free Kids. ...
... Increasing Sales of the Company,s Innovative Revenue Cycle ... charge capture technologies, today announced that it has ... led by existing investor Boston Millennia Partners. This ... growth of its Intelligent Charge Capture suite of ...
... Eating out, lack of social support and high-risk lifestyles ... with type 2 diabetes from controlling their condition, according ... 4,550 healthcare providers from 28 countries. , The ... Journal of Nursing and Healthcare of Chronic Illness , ...
... Field Museum for World Water Day March 22 CHICAGO, ... product safety testing services, will launch its water quality and ... Museum, 1400 S. Lake Shore Drive in Chicago, from 10:00 ... As part of the organization,s century-long commitment to public health ...
Cached Medicine News:Health News:The brain 'joins the dots' when drawing a cartoon face from memory 2Health News:Latest Osteoporosis Research Translated for Health Professionals to Use in Clinical Setting 2Health News:Kick Butts Day a Timely Prelude to Nebraska's June 1 Smoking Ban 2Health News:MedAptus Secures $6 Million Investment 2Health News:Barriers to diabetes care include restaurants and high-risk lifestyles, says international review 2Health News:Barriers to diabetes care include restaurants and high-risk lifestyles, says international review 3Health News:World Water Day 2009 Marks Launch of UL's Yearlong Commitment to Water Quality and Conservation Education 2Health News:World Water Day 2009 Marks Launch of UL's Yearlong Commitment to Water Quality and Conservation Education 3
... nebulizer system offers an affordable and ... COPD or other respiratory conditions. The ... gives patients the ability to take ... Its unique nebulizer design delivers powerful ...
Pediatric Compressor Nubulizer...
... very popular and competitively priced SportNeb ... compressor. Design enhancements include a neb ... optional black carry bag. The color ... The SportNeb also offers private labeling ...
... is an important part of managing the ... convenient products mean delivering the aerosolized medication ... while minimizing medication waste. Aerosol delivery with ... of Nebulizers, including the new NebuTech® HDN®, ...
Medicine Products: